Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Urology Reports
Erschienen in: Current Urology Reports 4/2014

01.04.2014 | Kidney Diseases (G Ciancio, Section Editor)

Update on Cryoablation for Treatment of Small Renal Mass: Oncologic Control, Renal Function Preservation, and Rate of Complications

verfasst von: Anil Kapoor, Yuding Wang, Brad Dishan, Stephen E. Pautler

Erschienen in: Current Urology Reports | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Cryoablation has become a popular treatment option for the treatment of small renal masses (SRMs) in patients who are not ideal surgical candidates. This relatively new therapy continues to be studied in terms of its efficacy and safety. Intermediate- and long-term data published over the past year suggest comparable rates of oncological control for established extirpative options (partial and radical nephrectomy). Studies evaluating its safety profile show a decreased rate of major and minor complications, as compared with surgery. Cyroablation also offers excellent preservation of kidney function and is a viable treatment option in patients with preexisting renal compromise. The purpose of the present review is to summarize current literature on cryoablation therapy in the management of SRMs, with emphasis on studies published over the past year.
Literatur
1.
2.
Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int. 2010;105(1):16–20.PubMedCentralPubMedCrossRef
3.
Lightfoot N, Conlon M, Kreiger N, et al. Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma. Eur Urol. 2000;37(5):521–7.PubMedCrossRef
4.•
Lagerveld BW, van Dekken H, van Leenders GJ, van der Zee JA. The role of pathology in small renal mass laparoscopic cryoablation. Adv Urol. 2012;2012, 539648. Small series evaluating the role of intraoperative biopsy during LCA as means for pathological diagnosis of SRMs.PubMedCentralPubMedCrossRef
5.
Faddegon S, Cadeddu JA. Does renal mass ablation provide adequate long-term oncologic control? Urol Clin N Am. 2012;39(2):181–90.CrossRef
6.
Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol. 2011;60(1):39–44.PubMedCrossRef
7.•
Laguna MP, Zondervan PJ, de la Rosette JJ. Focal therapy in the management of small renal masses. Curr Opin Urol. 2012;22(5):372–8. Review of current literature of all focal therapy for SRMs including ablative therapy such as CA and RFA, comparing oncological outcomes and complications.CrossRef
8.••
Klatte T, Grubmüller B, Waldert M, Weibl P, Remzi M. Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol. 2011;60(3):435–43. Systematic review and meta-analysis of all literature, comparing LCA and PN for oncological outcomes and complications. Ninety-eight articles are included, up to 2010.PubMedCrossRef
9.
Karam JA, Wood CG. Management of small renal masses: watch, cut, freeze, or fry? Eur Urol. 2012;61(5):905–6, discussion 906-7.PubMedCrossRef
10.•
Barwari K, Rosette J, Laguna M.P. Focal Therapy in Renal Cell Carcinoma: Which Modality Is Best? Eur Urol Supp. 2011. Excellent review of literature focusing on long-term data for focal therapy to access efficacy in terms of oncological outcomes and rates of complications for each therapy.
11.•
Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, et al. European Association of Urology Guideline Group. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010;58(3):398–406. Most up-to-date EAU guidelines for the treatment of SRM.PubMedCrossRef
12.•
Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH, et al. Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. J Urol. 2013;190(2):407–16. Most up-to-date AUA consensus guidelines for follow-up for localized SRM.PubMedCrossRef
13.•
Whitson JM, Harris CR, Meng MV. Population-based comparative effectiveness of nephron-sparing surgery vsablation for small renal masses. BJU Int. 2012;110(10):1438–43. Retrospective study using SEER database (all cases from 1998 to 2007) comparing nephron-sparing surgery (PN) versus ablation in terms of oncological outcomes.PubMedCrossRef
14.
Derweesh IH. Quality improvement of reporting standards for ablative studies: where do we stand? Can J Urol. 2012;19(5):6423.PubMed
15.•
Kang DC, Palmer DA, Zarei M, et al. A systematic review of the quality of evidence of ablative therapy for small renal masses. J Urol. 2012;187(1):44–7. Systematic review of current literature from 1995 to 2009, which concluded that high quality evidence comparing various treatments for SRMs was limited. Most are single-arm observation studies, suggesting caution with respect to any recommendations made on the basis of these studies, pending data from stronger study designs.PubMedCrossRef
16.
Zagoria RJ, Childs DD. Update on thermal ablation of renal cell carcinoma: oncologic control, technique comparison, renal function preservation, and new modalities. Curr Urol Rep. 2012;13(1):63–9.PubMedCrossRef
17.
Castro Jr A, Jenkins LC, Salas N, Lorber G, Leveillee RJ. Ablative therapies for small renal tumours. Nat Rev Urol. 2013;10(5):284–91.PubMedCrossRef
18.
Chalasani V, Martinez CH, Lim D, Abdelhady M, Chin JL. Surgical cryoablation as an option for small renal masses in patients who are not ideal partial nephrectomy candidates: intermediate-term outcomes. Can Urol Assoc J. 2010;4(6):399–402.PubMedCentralPubMed
19.
20.
Uchida M, Imaide Y, Sugimoto K, Uehara H, Watanabe H. Percutaneous cryosurgery for renal tumours. Br J Urol. 1995;75(2):132–6.PubMedCrossRef
21.
Maccini M, Sehrt D, Pompeo A, et al. Biophysiologic considerations in cryoablation: a practical mechanistic molecular review. Braz J Urol. 2011;37(6):693–6.CrossRef
22.•
Autorino R, Kaouk JH. Cryoablation for small renal tumors: current status and future perspectives. Urol Oncol. 2012;30(4 Suppl):S20–7. Excellent review of literature focusing on various cryoablative techniques, with select literature up to 2011 focusing on oncological outcomes, functional outcomes, and rates of complications.PubMedCrossRef
23.
Sprenkle PC, Mirabile G, Durak E, et al. The effect of argon gas pressure on ice ball size and rate of formation. J Endourol. 2010;24(9):1503–7.PubMedCrossRef
24.
Chosy SG, Nakada SY, Lee Jr FT, Warner TF. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol. 1998;159(4):1370–4.PubMedCrossRef
25.
Graversen JA, Mues AC, Landman J. Laparoscopic ablation of renal neoplasms. J Endourol. 2011;25(2):187–94.PubMedCrossRef
26.
Allen BC, Remer EM. Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging. Radiographics. 2010;30(4):887–900.PubMedCrossRef
27.
Haber GP, Colombo JR, Remer E. Synchronized real-time ultrasonography and three-dimensional computed tomography scan navigation during percutaneous renal cryoablation in a porcine model. J Endourol. 2010;24(3):333–7.PubMedCrossRef
28.
Autorino R, Haber GP, White MA, Stein RJ, Kaouk JH. New developments in renal focal therapy. J Endourol. 2010;24(5):665–72.PubMedCrossRef
29.•
Long CJ, Canter DJ, Smaldone MC, et al. Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses. Can J Urol. 2012;19(5):6417–22. Review of literature of case series reported lack of generalized reporting of tumor characteristics, including tumor location. Of those with tumor location reported, location determined the choice of treatment approach.PubMedCentralPubMed
30.
Patel SR, Hinshaw JL, Lubner MG, et al. Hydrodissection using an iodinated contrast medium during percutaneous renal cryoablation. J Endourol. 2012;26(5):463–6.PubMedCrossRef
31.•
Tsivian M, Kim CY, Caso JR, et al. Contrast enhancement on computed tomography after renal cryoablation: an evidence of treatment failure? J Endourol. 2012;26(4):330–5. Retrospective study of 172 CA procedures (PCA and LCA) with postoperative follow-up CT, showing a significant number (50 %) of post-op CT enhancement to resolve spontaneously and be benign. >35HU and delayed enhancement are more worrisome signs for disease recurrence.PubMedCrossRef
32.
Erdeljan P, Dhar M, Wignall G, Kozak R, Pautler SE. Thermal ablation of small renal masses: intermediate outcomes from a Canadian center. Can J Urol. 2011;18(5):5903–7.PubMed
33.••
Kapoor A, Touma NJ, Dib RE. Review of the efficacy and safety of cryoablation for the treatment of small renal masses. Can Urol Assoc J. 2013;7(1):E38–44. Systematic review of all literature up to 2011. Sixty-four studies were identified, with 23 studies reviewed with patient size >30. Efficacy in terms of oncological outcome and safety is presented.PubMedCentralPubMed
34.••
Tanagho YS, Roytman TM, Bhayani SB, et al. Laparoscopic cryoablation of renal masses: single-center long-termexperience. Urology. 2012;80(2):307–14. Single-center retrospective study of 62 consecutive patients from 2000 to 2005. This study represents the longest follow-up to date of post-LCA. Study shows high recurrence as disease free survival (DFS) is 80 %, but there is excellent preservation of renal function.
35.••
Haber GP, Lee MC, Crouzet S, Kamoi K, Gill IS. Tumour in solitary kidney: laparoscopic partial nephrectomy vs laparoscopic cryoablation. BJU Int. 2012;109(1):118–24. Long-term follow-up data comparing LPN and LCA for patients with SRMs in the setting of a solitary kidney, demonstrating superior oncological outcomes for LPN in terms of recurrence, as measured by DFS but not OS.PubMedCrossRef
36.
Spreafico C, Nicolai N, Lanocita R, et al. CT-guided percutaneous cryoablation of renal masses in selected patients. Radiol Med. 2012;117(4):593–605.PubMedCrossRef
37.•
Kim EH, Tanagho YS, Bhayani SB, et al. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours. BJU Int. 2013;111(6):872–9. Retrospective study of 124 patients, from 2005 to 2011 at a single institution, undergoing PCA, with intermediate follow-up of data at 30 months assessing for oncological efficacy, function preservation, and rate of complications.PubMedCrossRef
38.•
Atwell TD, Callstrom MR, Farrell MA, et al. Percutaneous renal cryoablation: local control at mean 26 months of followup. J Urol. 2010;184(4):1291–5. Retrospective study of 91 patients, from 2003 to 2007 at a single institution, undergoing PCA, with intermediate 2-year follow-up data.PubMedCrossRef
39.
Vricella GJ, Haaga JR, Adler BL, et al. Percutaneous cryoablation of renal masses: impact of patient selection and treatment parameters on outcomes. Urology. 2011;77(3):649–54.PubMedCrossRef
40.•
Goyal J, Verma P, Sidana A, Georgiades CS, Rodriguez R. Single-center comparative oncologic outcomes of surgical and percutaneous cryoablation for treatment of renal tumors. J Endourol. 2012;26(11):1413–9. Single-center retrospective review of 194 patients undergoing either PCA or surgical CA, with intermediate 3-year follow-up data.PubMedCrossRef
41.
Pirasteh A, Snyder L, Boncher N, et al. Cryoablation vs. radiofrequency ablation for small renal masses. Acad Radiol. 2011;18(1):97–100.PubMedCrossRef
42.••
El Dib R, Touma NJ, Kapoor A. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU Int. 2012;110(4):510–6. Systematic review and meta-analysis of all literature up to 2011, encompassing 31 studies comparing efficacy and complication of RFA versus CA.PubMedCrossRef
43.
44.••
Panumatrassamee K, Kaouk JH, Autorino R, et al. Cryoablation versus minimally invasive partial nephrectomy for small renal masses in the solitary kidney: impact of approach on functional outcomes. J Urol. 2013;189(3):818–22. Single-center retrospective study of renal function of solitary kidneys post CA or PN based on RENAL nephrometry score of tumor complexity. The RENAL nephrometry score is used as a predictive marker for intraoperative complications.PubMedCrossRef
45.
Altunrende F, Autorino R, Hillyer S, et al. Image guided percutaneous probe ablation for renal tumors in 65 solitary kidneys: functional and oncological outcomes. J Urol. 2011;186(1):35–41.PubMedCrossRef
46.
Pettus JA, Werle DM, Saunders W, et al. Percutaneous radiofrequency ablation does not affect glomerular filtration rate. J Endourol. 2010;24(10):1687–91.PubMedCrossRef
47.
Turna B, Kaouk JH, Frota R, Stein RJ, Kamoi K, Gill IS, et al. Minimally invasive nephron sparing management for renal tumors in solitary kidneys. J Urol. 2009;182(5):2150–7.PubMedCrossRef
48.
Tsivian M, Caso J, Kimura M, Polascik TJ. Renal function outcomes after laparoscopic renal cryoablation. J Endourol. 2011;25(8):1287–91.PubMedCrossRef
49.••
Sidana A, Aggarwal P, Feng Z, Georgiades CS, Trock BJ, Rodriguez R. Complications of renal cryoablation: a single center experience. J Urol. 2010;184(1):42–7. Retrospective single-center study of 162 patients undergoing PCA (101), LCA (52), or OCA (9) analysis for complications, with tumor size, number of cryoprobes used, anticoagulation status, and tumor location predictive for postoperative complications (hematoma formation, cardiovascular complications).PubMedCrossRef
50.
Haramis G, Graversen JA, Mues AC, et al. Retrospective comparison of laparoscopic partial nephrectomy versus laparoscopic renal cryoablation for small (<3.5 cm) cortical renal masses. J Laparoendosc Adv Surg Tech A. 2012;22(2):152–7.PubMedCrossRef
51.•
Atwell TD, Carter RE, Schmit GD, et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol. 2012;23(1):48–54. Large single-center retrospective study evaluating complications of pRFA and CA.PubMedCrossRef
52.•
Schmit GD, Thompson RH, Kurup AN, et al. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. J Urol. 2013;189(1):30–5. Large single-institution retrospective study of 627 patients undergoing RFA or CA with intermediate term follow-up of 27.8 months. RENAL nephrometry score was shown to predict treatment efficacy and post-op complications.PubMedCrossRef
53.••
Sisul DM, Liss MA, Palazzi KL, et al. RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis. Urology. 2013;81(4):775–80. Multiinstitution retrospective study of 154 consecutive patients with 30-day follow-up using the RENAL nephrometry score as predictor of intraoperative and postoperative complications of PCA and LCA.PubMedCrossRef
54.
Mouraviev V, Nosnik I, Sun L, et al. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience. Urology. 2007;69(2):311–4.PubMedCrossRef
55.•
Chang SL, Cipriano LE, Harshman LC, Garber AM, Chung BI. Cost-effectiveness analysis of nephron sparing options for the management of small renal masses. J Urol. 2011;185(5):1591–7. Decision model based on cost analysis of different treatment modalities for SRMs in a hypothetical healthy 65-year-old patient.PubMedCrossRef
56.
Bhan SN, Paulter SE, Shayegan B, Voss MD, Goeree RA, You JJ. Active surveillance, radiofrequency ablation, or cryoablation for the nonsurgical management of a small renal mass: a cost-utility analysis. Ann Surg Oncol. 2013;20(11):3675–84.PubMedCrossRef
Metadaten
Titel
Update on Cryoablation for Treatment of Small Renal Mass: Oncologic Control, Renal Function Preservation, and Rate of Complications
verfasst von
Anil Kapoor
Yuding Wang
Brad Dishan
Stephen E. Pautler
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Current Urology Reports / Ausgabe 4/2014
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-014-0396-3

Weitere Artikel der Ausgabe 4/2014

Current Urology Reports 4/2014 Zur Ausgabe

Urothelial Cancer (A Sagalowsky, Section Editor)

Increasing Utilization of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer in the United States

Prostate Cancer (D Parekh, Section Editor)

Penile Rehabilitation: The Evolutionary Concept in the Management of Erectile Dysfunction

Minimally Invasive Surgery (V Bird and M Desai, Section Editors)

Optimizing Use of the Holmium:YAG Laser for Surgical Management of Urinary Lithiasis

New Imaging Techniques (A Atala and A Rastinehad, Section Editors)

Imaging and Interventional Therapy for Varicoceles

Urothelial Cancer (A Sagalowsky, Section Editor)

Narrow-Band Imaging Evaluation of Bladder Tumors

Minimally Invasive Surgery (V Bird and M Desai, Section Editors)

Patient Positioning and Prevention of Injuries in Patients Undergoing Laparoscopic and Robot-Assisted Urologic Procedures

Neu im Fachgebiet Urologie

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise